Skip to main content
. 2022 Nov 18;14(11):e31660. doi: 10.7759/cureus.31660

Table 3. Sites of infection for patients treated with carbapenems.

Site of infection Suitability of therapy; number of cases
Appropriate Suboptimal Inappropriate Overall (n = 20)
Central nervous system 0 1 1 2
Respiratory system 5 3 0 8
Gastrointestinal system 1 1 0 2
Genitourinary system 4 0 1 5
Blood 3 0 0 3